The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A Phase 1 study to assess the safety, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activities of daily oral BAL101553, a novel tumor checkpoint controller (TCC) in adult patients with advanced solid tumors.
 
Rebecca Sophie Kristeleit
Honoraria - AstraZeneca; Clovis Oncology; Roche/Genentech
Consulting or Advisory Role - Clovis Oncology; Lytix Biopharma; Roche/Genentech; Sotio
Travel, Accommodations, Expenses - Basilea; Clovis Oncology; PiQuR
 
T.R. Jeffry Evans
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Baxter (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Karus Therapeutics (Inst)
Speakers' Bureau - Bristol-Myers Squibb; Celgene
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Daiichi Sankyo (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Merck (Inst); Roche/Genentech (Inst); Vertex (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Celgene
 
Juanita Lopez
No Relationships to Disclose
 
Sarah Slater
No Relationships to Disclose
 
Manolo D'Arcangelo
No Relationships to Disclose
 
Yvette Drew
Honoraria - AstraZeneca; Clovis Oncology
Consulting or Advisory Role - AstraZeneca; Clovis Oncology
 
Sola Adeleke
No Relationships to Disclose
 
Jessica Brown
No Relationships to Disclose
 
Donna Crawford
No Relationships to Disclose
 
Nikolaos Diamantis
No Relationships to Disclose
 
Paul Gougis
No Relationships to Disclose
 
Alexandar Tzankov
No Relationships to Disclose
 
Alison L. Hannah
Consulting or Advisory Role - Basilea
 
Stephanie Anderson
Employment - Basilea
 
Heidi A Lane
Employment - Basilea
Stock and Other Ownership Interests - Basilea
Research Funding - Basilea
 
Anne Schmitt-Hoffmann
Employment - Basilea
Stock and Other Ownership Interests - Basilea
 
Martina Maurer
Employment - Basilea
Stock and Other Ownership Interests - Basilea
 
Felix Bachmann
Employment - Basilea
Stock and Other Ownership Interests - Basilea
 
Marc Frederick Engelhardt
Employment - Basilea
Stock and Other Ownership Interests - Basilea
Patents, Royalties, Other Intellectual Property - Basilea
 
Elizabeth R. Plummer
Honoraria - Bristol-Myers Squibb; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Biomarin; Clovis Oncology; Karus Therapeutics; Mission Therapeutics; MSD Oncology; Novartis; Roche/Genentech; Tesaro; Vertex
Speakers' Bureau - Novartis
Research Funding - AstraZeneca/MedImmune (Inst); Clovis Oncology (Inst); Eisai (Inst); Etherapeutics (Inst); Ipsen (Inst); vertex (Inst)
Patents, Royalties, Other Intellectual Property - Named on patent of use of PARP inhibitor rucaparib (Inst)
Travel, Accommodations, Expenses - MSD Oncology; Roche/Genentech